Literature DB >> 12650523

Tetracycline-inducible system for regulation of skeletal muscle-specific gene expression in transgenic mice.

Mischala A Grill1, Mark A Bales, Amber N Fought, Kristopher C Rosburg, Stephanie J Munger, Parker B Antin.   

Abstract

Tightly regulated control of over-expression is often necessary to study one aspect or time point of gene function and, in transgenesis, may help to avoid lethal effects and complications caused by ubiquitous over-expression. We have utilized the benefits of an optimized tet-on system and a modified muscle creatine kinase (MCK) promoter to generate a skeletal muscle-specific, doxycycline (Dox) controlled over-expression system in transgenic mice. A DNA construct was generated in which the codon optimized reverse tetracycline transactivator (rtTA) was placed under control of a skeletal muscle-specific version of the mouse MCK promoter. Transgenic mice containing this construct expressed rtTA almost exclusively in skeletal muscles. These mice were crossed to a second transgenic line containing a bi-directional promoter centered on a tet responder element driving both a luciferase reporter gene and a tagged gene of interest; in this case the calpain inhibitor calpastatin. Compound hemizygous mice showed high level, Dox dependent muscle-specific luciferase activity often exceeding 10,000-fold over non-muscle tissues of the same mouse. Western and immunocytochemical analysis demonstrated similar Dox dependent muscle-specific induction of the tagged calpastatin protein. These findings demonstrate the effectiveness and flexibility of the tet-on system to provide a tightly regulated over-expression system in adult skeletal muscle. The MCKrtTA transgenic lines can be combined with other transgenic responder lines for skeletal muscle-specific over-expression of any target gene of interest.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  2003        PMID: 12650523     DOI: 10.1023/a:1022119005836

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  39 in total

1.  Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances.

Authors:  U Baron; H Bujard
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart.

Authors:  M L Valencik; J A McDonald
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

Review 3.  Choose your target.

Authors:  M R Capecchi
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

4.  Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.

Authors:  L Cordier; A A Hack; M O Scott; E R Barton-Davis; G Gao; J M Wilson; E M McNally; H L Sweeney
Journal:  Mol Ther       Date:  2000-02       Impact factor: 11.454

5.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 6.  The vagaries of variegating transgenes.

Authors:  D I Martin; E Whitelaw
Journal:  Bioessays       Date:  1996-11       Impact factor: 4.345

7.  Multiple effects of genetic background on variegated transgene expression in mice.

Authors:  Margaret L Opsahl; Margaret McClenaghan; Anthea Springbett; Sarah Reid; Richard Lathe; Alan Colman; C Bruce A Whitelaw
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

8.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

Authors:  D No; T P Yao; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

9.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

Authors:  P A Furth; L St Onge; H Böger; P Gruss; M Gossen; A Kistner; H Bujard; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

10.  Position-independent, high-level expression of the human beta-globin gene in transgenic mice.

Authors:  F Grosveld; G B van Assendelft; D R Greaves; G Kollias
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

View more
  18 in total

1.  CORP: Using transgenic mice to study skeletal muscle physiology.

Authors:  C Brooks Mobley; Ivan J Vechetti; Taylor R Valentino; John J McCarthy
Journal:  J Appl Physiol (1985)       Date:  2020-02-27

2.  Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction.

Authors:  Satoshi Araki; Yasuhiro Izumiya; Shinsuke Hanatani; Taku Rokutanda; Hiroki Usuku; Yuichi Akasaki; Toru Takeo; Naomi Nakagata; Kenneth Walsh; Hisao Ogawa
Journal:  Circ Heart Fail       Date:  2011-12-01       Impact factor: 8.790

3.  Creb coactivators direct anabolic responses and enhance performance of skeletal muscle.

Authors:  Nelson E Bruno; Kimberly A Kelly; Richard Hawkins; Mariam Bramah-Lawani; Antonio L Amelio; Jerome C Nwachukwu; Kendall W Nettles; Michael D Conkright
Journal:  EMBO J       Date:  2014-03-27       Impact factor: 11.598

4.  BDNF is a mediator of glycolytic fiber-type specification in mouse skeletal muscle.

Authors:  Julien Delezie; Martin Weihrauch; Geraldine Maier; Rocío Tejero; Daniel J Ham; Jonathan F Gill; Bettina Karrer-Cardel; Markus A Rüegg; Lucía Tabares; Christoph Handschin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-18       Impact factor: 11.205

5.  DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle.

Authors:  Jing Zhang; Eunjin Oh; Karla E Merz; Arianne Aslamy; Rajakrishnan Veluthakal; Vishal A Salunkhe; Miwon Ahn; Ragadeepthi Tunduguru; Debbie C Thurmond
Journal:  Diabetologia       Date:  2019-02-01       Impact factor: 10.122

6.  Akt1-mediated fast/glycolytic skeletal muscle growth attenuates renal damage in experimental kidney disease.

Authors:  Shinsuke Hanatani; Yasuhiro Izumiya; Satoshi Araki; Taku Rokutanda; Yuichi Kimura; Kenneth Walsh; Hisao Ogawa
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

7.  FGF21 is an Akt-regulated myokine.

Authors:  Yasuhiro Izumiya; Holly A Bina; Noriyuki Ouchi; Yuichi Akasaki; Alexei Kharitonenkov; Kenneth Walsh
Journal:  FEBS Lett       Date:  2008-10-21       Impact factor: 4.124

8.  Targeted delivery of HGF to the skeletal muscle improves glucose homeostasis in diet-induced obese mice.

Authors:  Viviana Sanchez-Encinales; Irene Cozar-Castellano; Adolfo Garcia-Ocaña; Germán Perdomo
Journal:  J Physiol Biochem       Date:  2015-10-27       Impact factor: 4.158

9.  Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice.

Authors:  Yasuhiro Izumiya; Teresa Hopkins; Carl Morris; Kaori Sato; Ling Zeng; Jason Viereck; James A Hamilton; Noriyuki Ouchi; Nathan K LeBrasseur; Kenneth Walsh
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

10.  A new mouse model for temporal- and tissue-specific control of extracellular superoxide dismutase.

Authors:  Yani Zou; Chih-Hsin Chen; John R Fike; Ting-Ting Huang
Journal:  Genesis       Date:  2009-03       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.